Follow
Stefano Fagiuoli, MD
Stefano Fagiuoli, MD
Direttore Gastroenterologia Epatologia e Trapiantologia - Ospedale Papa Giovanni XXIII, Bergamo
Verified email at asst-pg23.it
Title
Cited by
Cited by
Year
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
22592009
Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
P Marcellin, TT Chang, SG Lim, MJ Tong, W Sievert, ML Shiffman, ...
New England Journal of Medicine 348 (9), 808-816, 2003
20742003
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: a retrospective study
S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ...
Hepatology 45 (3), 579-587, 2007
7662007
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R Golfieri, E Giampalma, M Renzulli, R Cioni, I Bargellini, C Bartolozzi, ...
British journal of cancer 111 (2), 255-264, 2014
6442014
Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre-and Post-Liver Transplantation Patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
5802003
Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis
F Coccolini, F Catena, M Pisano, F Gheza, S Fagiuoli, S Di Saverio, ...
International journal of surgery 18, 196-204, 2015
5752015
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
5102018
Gut microbiota in autism and mood disorders
F Mangiola, G Ianiro, F Franceschi, S Fagiuoli, G Gasbarrini, A Gasbarrini
World journal of gastroenterology 22 (1), 361, 2016
4942016
Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features
S Fasolato, P Angeli, L Dallagnese, G Maresio, E Zola, E Mazza, ...
Hepatology 45 (1), 223-229, 2007
4492007
High rates of 30-day mortality in patients with cirrhosis and COVID-19
M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ...
Journal of hepatology 73 (5), 1063-1071, 2020
4022020
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
U Cillo, A Vitale, M Bassanello, P Boccagni, A Brolese, G Zanus, P Burra, ...
Annals of Surgery 239 (2), 150-159, 2004
3742004
Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results
E Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Liver Transplantation 13 (3), 349-360, 2007
3492007
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study
LS Belli, M Berenguer, PA Cortesi, M Strazzabosco, SR Rockenschaub, ...
Journal of hepatology 65 (3), 524-531, 2016
3402016
Association between reactive oxygen species and disease activity in chronic hepatitis C
N De Maria, A Colantonl, S Fagiuoli, GJ Liu, BK Rogers, F Farinati, ...
Free Radical Biology and Medicine 21 (3), 291-295, 1996
3091996
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ...
Digestive and Liver Disease 39 (5), 397-408, 2007
2882007
Response to interferon α therapy is influenced by the iron content of the liver
DH Van Thiel, L Friedlander, S Fagiuoli, HI Wright, W Irish, JS Gavaler
Journal of hepatology 20 (3), 410-415, 1994
2811994
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ...
The Lancet Oncology 21 (7), 947-956, 2020
2792020
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
U Cillo, M Bassanello, A Vitale, FA Grigoletto, P Burra, S Fagiuoli, ...
Journal of hepatology 40 (1), 124-131, 2004
2522004
Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of …
M Pompili, VG Mirante, G Rondinara, LR Fassati, F Piscaglia, S Agnes, ...
Liver transplantation 11 (9), 1117-1126, 2005
2472005
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ...
Journal of hepatology 66 (3), 552-559, 2017
2212017
The system can't perform the operation now. Try again later.
Articles 1–20